Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Monsanto/Alnylam in ten-year alliance

Monsanto has entered into a ten-year strategic alliance with US pharmaceutical company Alnylam Pharmaceuticals (Cambridge, Massachusetts) to use Alnylam’s RNAi-based technologies in its BioDirect biopesticide platform. Monsanto will pay Alnylam $29.2 million for exclusive global rights to use its technology and intellectual property for agricultural applications, including the right to grant sub-licences. In addition, Alnylam will receive milestone payments and further funding for collaborative research efforts, and royalties on products utilising its technology. Monsanto’s BioDirect technology employs RNA molecules to control the expression and regulation of genes in weeds, pests and pathogens. They will be applied as sprayable non-genetically modified products to enhance the performance of existing herbicides and to target specific pests and diseases ( Agrow No 641, p 2).



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts